-
公开(公告)号:US07531564B2
公开(公告)日:2009-05-12
申请号:US11636947
申请日:2006-12-11
Applicant: Michael S. Malamas , Robert E. McDevitt , Iwan Gunawan , Eric S. Manas , Michael D. Collini , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , C. Richard Lyttle
Inventor: Michael S. Malamas , Robert E. McDevitt , Iwan Gunawan , Eric S. Manas , Michael D. Collini , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , C. Richard Lyttle
IPC: A61K31/42
CPC classification number: C07D263/57 , C07D235/18 , C07D277/66 , C07D413/04 , C07D417/04
Abstract: This invention provides estrogen receptor modulators of formula I, having the structure wherein R1, R2, R2a, R3, R3a, and R4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明提供式I的雌激素受体调节剂,其具有如说明书中所定义的R 1,R 2,R 2a,R 3,R 3a和R 4以及X或其药学上可接受的盐的结构。
-
12.Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents 失效
Title translation: 萘基苯并恶唑和苯并异恶唑作为雌激素公开(公告)号:US06960607B2
公开(公告)日:2005-11-01
申请号:US10316641
申请日:2002-12-11
Applicant: Michael S. Malamas , Iwan Gunawan , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert
Inventor: Michael S. Malamas , Iwan Gunawan , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert
IPC: C07D231/56 , C07D261/20 , C07D263/56 , C07D263/57 , C07D263/54 , A61K31/42
CPC classification number: C07D263/57 , C07D231/56 , C07D261/20
Abstract: This invention provides estrogen receptor modulators of formula I, having the structure wherein R1, R2, R3, and R4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明提供式I的雌激素受体调节剂,其具有其中R 1,R 2,R 3和R 4的结构 和/或其说明书中所定义的X或其药学上可接受的盐。
-
公开(公告)号:US06903238B2
公开(公告)日:2005-06-07
申请号:US10316446
申请日:2002-12-11
Applicant: Robert E. McDevitt , Folake O. Adebi , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert
Inventor: Robert E. McDevitt , Folake O. Adebi , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert
IPC: A61K31/12 , A61K31/421 , A61K31/426 , A61K31/445 , A61K31/495 , A61K31/537 , A61K31/54 , C07C49/747 , C07C49/755 , C07C225/20 , C07C323/22 , C07C49/115
CPC classification number: A61K31/445 , A61K31/12 , A61K31/421 , A61K31/426 , A61K31/495 , A61K31/537 , A61K31/54 , C07C49/747 , C07C49/755 , C07C225/20 , C07C323/22 , C07C2602/08
Abstract: This invention provides estrogen receptor modulators of formula I, having the structure R1, R2, and R3 are as defined in the specification, or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明提供式I的雌激素受体调节剂,其结构是R 1,R 2,R 3和R 3如说明书中所定义, 或其药学上可接受的盐。
-
14.5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents 失效
Title translation: 5,11-二氧杂 - 苯并[b]芴-10-酮和5-氧杂-11-硫杂 - 苯并[b]芴-10-酮作为雌激素剂公开(公告)号:US06559177B2
公开(公告)日:2003-05-06
申请号:US10122783
申请日:2002-04-15
Applicant: Christopher P. Miller , Michael D. Collini , Heather A. Harris , James C. Keith, Jr.
Inventor: Christopher P. Miller , Michael D. Collini , Heather A. Harris , James C. Keith, Jr.
IPC: A61K31352
CPC classification number: C07D493/04 , C07D495/04
Abstract: This invention provides estrogen receptor modulators of formula 1, having the structure wherein X, Y1, Y2, Y3, Y4, Z1, Z2, Z3, and Z4 are as defined in the specification, or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明提供具有其中X,Y 1,Y 2,Y 3,Y 4,Z 1,Z 2,Z 3和Z 4如本说明书中所定义的结构的式1的雌激素受体调节剂或其药学上可接受的盐。
-
-
-